A clinical trail to study the efficacy of Eptifibatide in acute coronary syndrome in Asian Indian patients

Efficacy of Eptifibatide in acute coronary syndrome in Asian Indian patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/10/002068

Enrollment

250

Registered

2011-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acute Coronary Syndrome

Interventions

Intervention1: Eptifibatide: 135 microgram/kg followed by infusion of 0.5 microgram/kg/min for 24 hours. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Acute Coronary Syndrome under going percutaneous intervention(PCI)

Exclusion criteria

Exclusion criteria: 1. Severe renal insufficiency 2.Thrombocytopenia 3. Hemorrhagic stroke 4.Local Systemic Bleeds

Design outcomes

Primary

Measure	Time frame
All cause death,Heammoragic stroke, Thrombocytopenia, severe renal insufficiencyTimepoint: 15 Days	—

Secondary

Measure	Time frame
All cause death,Heammoragic stroke, Thrombocytopenia, severe renal insufficiencyTimepoint: 1 Month	—

Countries

India

Contacts

Public ContactDr Maddury Jyotsna

Nizams institute of medical sciences(NIMS)

mail2jyotsna@rediffmail.com040-23300483

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026